Thrive’s CancerSEEK uses blood tests for early multi-cancer detection
Endpoints News - 28-Apr-2020Demonstrated in a large prospective study involving patients without cancer history
Previously the Live Forever Club – now more focused on campaigning for radical life extension in the UK
Biotechnology company, Massachusetts
Thrive Earlier Detection, our goal is to transform this outlook: to catch cancer earlier, when it can be more effectively treated. We are developing CancerSEEK, a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages. Our approach goes beyond a cancer diagnosis. We are developing a platform that will serve as a resource to help patients and their families maneuver the often confusing and overwhelming path that follows a cancer diagnosis.
Visit website: https://thrivedetect.com/
Details last updated 02-May-2020
Demonstrated in a large prospective study involving patients without cancer history